ICCC
ImmuCell Corporation
10.00$
-0.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 41.4% | 38.9% | 43.2% | 49.9% | 52.7% | 50.9% | 55.3% | 55.0% | 58.8% | 74.8% | 70.0% | 58.6% | |
| 58.6% | 61.1% | 56.8% | 50.1% | 47.3% | 49.1% | 44.7% | 45.0% | 41.2% | 25.2% | 30.0% | 41.4% | |
| 28.7% | 12.1% | 13.0% | 19.6% | 32.0% | 26.9% | 28.4% | 21.7% | 24.2% | 25.2% | 14.7% | 11.0% | |
| 15.3% | 12.6% | 15.2% | 14.6% | 15.8% | 12.3% | 11.2% | 9.0% | 12.2% | 12.2% | 8.4% | 11.6% | |
| 61.3% | 40.4% | 47.5% | 52.4% | 66.8% | 56.1% | 53.7% | 43.6% | 53.6% | 58.1% | 36.2% | 35.4% | |
| -2.7% | 20.7% | 9.3% | -2.3% | -13.2% | -7.0% | -9.0% | 1.3% | -12.4% | -32.9% | -6.2% | 6.0% | |
| 0.8% | 0.8% | 1.7% | 2.1% | 3.9% | 3.1% | 2.7% | 1.6% | 1.8% | 2.6% | 2.1% | 1.6% | |
| -3.4% | 20.2% | 7.9% | -4.2% | -16.9% | -9.2% | -6.7% | -0.4% | -13.4% | -33.0% | -8.1% | -3.7% | |
| -1.2% | 8.3% | 2.6% | -2.6% | 4.2% | 0.2% | -0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -2.2% | 11.9% | 5.3% | -1.6% | -21.1% | -9.4% | -6.7% | -0.4% | -13.4% | -33.1% | -8.1% | -3.8% | |
| 3.3% | 25.9% | 18.0% | 6.3% | 0.8% | 9.6% | 6.3% | 14.0% | 1.0% | -14.3% | 4.0% | 7.7% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.